Hanmi Pharm closer to Celltrion in market capitalization
Hanmi Pharm has exceeded KRW 8 trillion in market capitalization from a series of technology exports.
It has gotten closer by KRW 200 billion to the leading market capitalization(KRW 8.626 trillion) in the pharmaceutical and biopharmaceutical industry, owned by Celltrion; Hanmi is about to becom...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
